The research team followed the PRISMA-ScR reporting guidelines, the accepted standard for scoping reviews, to map the existing literature on health anxiety in healthcare workers. Their search identified 35 peer-reviewed articles that met inclusion criteria, a body of evidence that on its face might seem modest for a workforce of millions worldwide. What is more striking is the temporal concentration of that evidence: 29 of the 35 studies were conducted during the Covid-19 pandemic. The pandemic, the authors argue, acted as a kind of natural experiment, thrusting healthcare workers into prolonged contact with a novel, deadly, and poorly understood pathogen while simultaneously flooding them with personal risk, moral distress, and the sight of unprecedented numbers of patients dying.

To move beyond a narrative summary, the researchers conducted an exploratory quantitative summary of the 19 studies that reported health anxiety data in a form suitable for pooling. The result was a combined estimate of health anxiety prevalence or severity among healthcare professionals, but the authors are careful, almost emphatic, about how that figure should be read. The between-study heterogeneity statistic, I-squared, came out at 99.8 percent, a value so extreme that it approaches the mathematical ceiling. In practical terms, this means the individual studies differed so profoundly in their populations, instruments, cutoffs, and contexts that any single pooled number is more of a signpost than a verdict. The team explicitly labels their estimate exploratory, a decision that reflects a growing sophistication in how systematic reviewers handle heterogeneous evidence rather than forcing false precision onto it.

Despite that heterogeneity, clear patterns emerged in the contributing factors. Health anxiety in healthcare professionals was associated with context-dependent variables including age, profession, gender, and broader sociodemographic characteristics. Younger workers, for instance, have repeatedly shown higher health anxiety scores in pandemic-era studies, a finding consistent with the general-population literature in which younger adults often report more illness-related worry. Professional role mattered as well, with frontline and direct-care occupations generally carrying greater exposure and, in several studies, greater anxiety. Gender differences appeared in multiple analyses, echoing the well-documented tendency for women to report higher health anxiety than men. None of these associations is deterministic, but together they sketch the outline of a workforce in which vulnerability to illness-related worry is unevenly distributed and shaped by the specific conditions of each worker’s job and life.

The conceptual heart of the paper is the authors’ use of the Cognitive Model of health anxiety as a framework for interpreting their findings. This model, rooted in cognitive-behavioural theory, holds that health anxiety is maintained by misinterpreting bodily sensations and health-related information as signs of serious disease, reinforced by safety behaviours such as repeated checking and reassurance seeking. The authors propose that elevated health anxiety in healthcare professionals may reflect processes consistent with vicarious trauma, the cumulative psychological impact of repeated exposure to the trauma of others. A nurse who has watched dozens of patients deteriorate from an infectious disease does not merely witness that trauma; the workplace ensures that the raw material of catastrophic health beliefs, the deteriorating patient, the abnormal scan, the sudden death, is a daily professional companion.

This framing has a certain explanatory elegance. Vicarious trauma has been extensively documented in professions such as emergency response, palliative care, and oncology, where it is understood to erode wellbeing, distort worldview, and contribute to burnout and post-traumatic stress. The cognitive model of health anxiety suggests a plausible mechanism by which such exposure could translate into illness anxiety specifically: the healthcare worker’s expert knowledge, normally a protective asset, becomes a double-edged sword. Knowing precisely how a constellation of symptoms can unfold into a fatal disease may make benign bodily sensations harder to dismiss, not easier. A headache is no longer just a headache when you have seen what brain metastases look like on a CT scan. The very training that equips clinicians to care for the sick may prime them to catastrophically interpret their own bodies.

The consequences of unaddressed health anxiety in this workforce are not trivial. Health anxiety in any population is associated with impaired mental and physical wellbeing, excessive healthcare utilisation, and diminished quality of life. In healthcare professionals, those costs compound: a clinician preoccupied with their own health may suffer reduced concentration, increased absenteeism, and higher risk of burnout and departure from the profession, pressures that ripple outward to patients and to health systems already strained by workforce shortages. The authors argue that health anxiety should be recognised as an occupational safety issue, placing it in the same category as needlestick injuries, infectious exposure, and workplace violence, hazards that health services are expected to anticipate, monitor, and mitigate rather than treat as private misfortunes.

One of the more encouraging threads in the review concerns treatment. Effective interventions for health anxiety already exist, most prominently cognitive behavioural therapy, which has a robust evidence base in general populations, with acceptance and commitment therapy emerging as another option supported by randomised controlled trials. The problem, the authors emphasise, is not a lack of therapeutic tools but a lack of understanding of how those tools translate to healthcare workers, whose illness beliefs are shaped by professional knowledge and occupational exposure in ways that standard treatment protocols were never designed to address. The aetiology of health anxiety in this group, its specific risk factors, and the optimal timing and format of intervention all remain open questions. A clinician may also face unique barriers to seeking help, including stigma, fear of professional consequences, and the pervasive culture of self-reliance that pervades medical training.

The methodological limitations of the underlying literature are themselves a finding of the review. The dominance of pandemic-era cross-sectional studies means the field lacks longitudinal data that could establish whether health anxiety in healthcare workers precedes occupational stress or follows from it, whether it fluctuates with disease outbreaks, and whether it resolves or consolidates over time. The extreme heterogeneity in measurement, with studies using different instruments and cutoffs, including the Short Health Anxiety Inventory, complicates comparison across settings. The authors’ decision to present their pooled estimate as exploratory rather than definitive is a model of responsible synthesis, resisting the temptation to headline a single prevalence figure that the data cannot support.

What the review ultimately delivers is an agenda. The authors call for further research to elucidate the mechanisms underlying health anxiety in healthcare professionals and to develop strategies for both prevention and treatment, work that would need to disentangle the contributions of vicarious trauma, professional knowledge, personality, and workplace conditions. If the cognitive model and the vicarious trauma hypothesis hold up under that scrutiny, the implications for health systems are concrete: screening programs for at-risk roles, psychologically informed occupational health services, and adapted psychological therapies that account for the clinician’s dual identity as healer and potential patient. The Covid-19 pandemic revealed how quickly the healthcare workforce can be pushed to its psychological limits. This study suggests that one of the injuries sustained in that pressure, the fear of illness itself, has been hiding in plain sight, and that recognising it as an occupational hazard is the first step toward treating it.

Subject of Research: Health anxiety among healthcare professionals as a potential occupational hazard

Article Title: Exploring health anxiety among healthcare professionals: a scoping review and exploratory quantitative summary of health anxiety findings

Article References: Schlub, G. M., Freeman, L., Barlow-Stewart, K., & McEwen, A. (2026). Exploring health anxiety among healthcare professionals: a scoping review and exploratory quantitative summary of health anxiety findings. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15573-0

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15573-0

Keywords: health anxiety, healthcare professionals, scoping review, vicarious trauma, Covid-19 pandemic, occupational health, cognitive behavioural therapy, mental health, illness anxiety disorder, burnout, Short Health Anxiety Inventory, BMC Health Services Research

The research team, led by Duygu Gulec Satir of Ege University’s Nursing Faculty, set out to fill a conspicuous gap in the literature. While cyberchondria has been studied in general populations and among people with chronic illnesses, little was known about how the hormonal fluctuations of the menstrual cycle interact with online health information-seeking behavior. Premenstrual syndrome affects a large proportion of women of reproductive age, and its symptoms overlap with a wide range of other conditions, from thyroid disorders to depression. That diagnostic ambiguity, the researchers reasoned, might make young women with PMS especially vulnerable to compulsive searching, as they attempt to self-diagnose symptoms that shift predictably with their cycle.

The study recruited 451 nursing students, a population chosen because young university women are both heavy internet users and at an age when PMS symptoms are common. Participants completed an online questionnaire that included the Premenstrual Syndrome Scale, which screens for and quantifies the severity of premenstrual symptoms, and the Cyberchondria Severity Scale, a validated 15-item instrument that measures the distress, compulsion, and reassurance-seeking dimensions of excessive online health searching. The researchers also collected data on daily internet use, perceived stress, economic income, and alcohol consumption, allowing them to statistically separate the effect of PMS from other factors known to influence both internet habits and health anxiety.

The findings paint a coherent picture of a digitally mediated feedback loop. Students whose scores suggested possible PMS reported greater online health information-seeking behaviors than their peers, and PMS scores correlated positively and significantly with cyberchondria severity scores. When the team ran a multiple linear regression controlling for income, alcohol use, perceived stress, and time spent online, PMS severity remained an independent predictor of cyberchondria. In other words, the association was not simply explained by the fact that anxious or stressed people spend more time on the internet; the premenstrual symptom burden itself appeared to drive the compulsive searching pattern.

Notably, the topics these young women searched for most frequently were menstrual irregularity, dysmenorrhea, and premenstrual symptoms themselves. This is a telling detail. Rather than browsing randomly about exotic diseases, the students were searching for information directly related to their own lived experience, seeking explanations for bodily changes they could feel but not fully understand. The internet, in this sense, functions as an accessible first-line consultant, available at any hour and free of charge. Yet the quality and framing of what they encounter online can vary enormously, and for someone whose symptoms fluctuate with her hormonal cycle, contradictory or alarming search results may amplify uncertainty rather than resolve it.

The study also found that daily internet use was positively associated with both PMS and cyberchondria scores, although the researchers were careful to note that these associations were small in magnitude. That caveat matters. The data do not suggest that spending hours online causes PMS, or that PMS inevitably produces cyberchondria. Instead, the relationships are statistical tendencies observed in a single snapshot of time. Because the design was cross-sectional, measuring exposure and outcome simultaneously, it cannot establish which comes first. It is plausible that women troubled by premenstrual symptoms search more, that compulsive searchers become more attuned to and distressed by bodily sensations, or that both dynamics reinforce each other in a cycle that future longitudinal studies will need to disentangle.

Cyberchondria itself is a concept that has gained increasing attention as smartphones have made health information permanently accessible. Psychologists describe it as a maladaptive form of health anxiety in which repeated online searches provide only fleeting reassurance, followed by renewed worry, often triggered by encountering serious conditions that share superficial features with benign symptoms. The Cyberchondria Severity Scale used in this study captures this compulsion, distress, and excessiveness, and its 15-item short form has become a standard tool in the field. The Turkish research team’s application of it to a menstrual health context is one of the first attempts to connect cyclical hormonal symptomatology with this digital-era anxiety pattern.

The choice of nursing students as the study population adds an interesting layer of interpretation. These are young women with formal health education, presumably better equipped than the average internet user to evaluate medical sources critically. If even a health-literate population shows elevated cyberchondria in association with PMS, the authors’ concern about the broader population of young women may be warranted. At the same time, the sample’s homogeneity, limited to nursing students at Turkish universities, means the findings cannot be generalized to all young women, men, or older age groups without further research. The authors themselves frame the work as descriptive and correlational, an early mapping of a territory rather than a definitive causal account.

What the study does establish is a practical signal for healthcare professionals. The authors conclude that clinicians should guide young women with PMS toward reliable online health resources and support the development of digital health literacy skills. This recommendation reflects a pragmatic view of the internet’s role in health behavior: rather than telling patients to stop searching, which rarely works, providers can redirect that energy toward vetted sources and teach the skills needed to interpret what they find. For menstrual health specifically, this could mean pointing patients to evidence-based resources that explain the normal range of premenstrual experiences, the red flags that genuinely warrant medical evaluation, and the ways hormonal cycles can legitimately produce a wide spectrum of physical and emotional symptoms.

The research also arrives at a moment of broader cultural conversation about how digital platforms shape health behavior, from TikTok trends that popularize self-diagnosed conditions to algorithmic feeds that can funnel users toward increasingly alarming content. This study does not examine social media algorithms, but it contributes an important piece of evidence: a physiological, cyclical condition like PMS is associated with measurable increases in problematic health-related internet use. As the authors and the journal’s indexed subject areas suggest, the intersection of gynecology, cyberpsychology, and mental health is likely to attract growing research attention. For now, the message for young women navigating premenstrual symptoms is nuanced: the impulse to search is understandable and common, but the searching itself may carry a psychological cost, and a conversation with a healthcare provider, paired with trustworthy online sources, remains the more reliable path to reassurance.

Subject of Research: The relationship between premenstrual syndrome, internet use behaviors, and cyberchondria in young women

Article Title: Cyberchondria levels and internet use behaviors of young women with premenstrual syndrome: a cross-sectional study

Article References: Gulec Satir, D., Kavlak, O., Tetik, S., & Başak, H. (2026). Cyberchondria levels and internet use behaviors of young women with premenstrual syndrome: a cross-sectional study. BMC Psychology. https://doi.org/10.1186/s40359-026-05729-2

Image Credits: AI Generated

DOI: 10.1186/s40359-026-05729-2

Keywords: premenstrual syndrome, cyberchondria, internet use, health anxiety, digital health literacy, online health information-seeking, young women, menstrual health, cross-sectional study, nursing students, cyberpsychology, mental health

The study was led by Gülhan Yiğitalp of Dicle University, together with Kadriye Olğaç Ak and Vasfiye Bayram Değer of Mardin Artuklu University. Mardin was an ideal setting for such an investigation. The city sits in a region where Kurdish, Arab, Turkish, and Assyrian communities have lived side by side for centuries, often maintaining distinct languages, religious traditions, and health practices despite sharing the same streets and the same health care system. By sampling women aged 20 to 69 from all four groups, the researchers could ask a question that single-community studies cannot answer: when the health system is nominally the same for everyone, why do prevention behaviors differ so dramatically between ethnic groups?

The team designed the work as a descriptive, cross-sectional survey, and they took the statistical groundwork seriously. Before recruiting a single participant, they performed an a priori power analysis using G*Power 3.1 software, calculating how many women would be needed to detect meaningful effects in a multiple linear regression framework. That calculation settled on 403 participants. Each woman completed a personal information form along with three validated instruments: the Health Anxiety Scale, which measures worry and vigilance about illness; the Health Literacy Scale, which captures the ability to find, understand, and apply health information; and the ASSISTS scale, formally known as the Scale to Determine Factors Affecting Women’s Breast Cancer Prevention Behaviors. The data were analyzed in SPSS 22.0 using chi-square tests, analysis of variance with post-hoc comparisons, Pearson correlations, and linear regression.

The headline result concerned clinical breast examinations, in which a trained health professional checks the breasts for lumps or other changes. Women of Assyrian origin underwent these examinations most frequently, with 64.0 percent reporting the practice. At the other end of the spectrum, only 22.8 percent of women of Kurdish origin had undergone a clinical breast examination—a gap of more than forty percentage points between two communities living in the same city. Because clinical breast examination is a frontline tool for detecting breast cancer at earlier, more treatable stages, a disparity of that magnitude is not a statistical curiosity. It represents a real difference in the odds that a tumor will be found in time, and it points to barriers—whether informational, cultural, or structural—that fall unevenly across ethnic lines.

Health anxiety told a more nuanced story. Women of Assyrian and Arab origin reported significantly higher levels of anxiety about their health than women of Turkish origin, a difference that reached statistical significance at p = 0.002. At first glance, elevated anxiety might seem purely negative, a source of distress to be reduced. But in the context of cancer prevention, the relationship between worry and action is complicated. A moderate degree of health concern can motivate women to seek examinations and pay attention to their bodies, while too little concern can breed complacency. The study’s pattern—higher anxiety in the group that also screened most often—hints that emotional engagement with health may be one of the engines driving preventive behavior, though the authors are careful to frame this as a relationship to be explored rather than a simple prescription.

Health literacy, by contrast, peaked in a different community. Women of Turkish origin scored significantly higher than women of the other three groups on total health literacy and on two of its most sophisticated dimensions: interactive literacy, the ability to communicate with health providers and extract useful information from them, and critical literacy, the capacity to evaluate health information and apply it to one’s own circumstances. The difference was robust, with p values below 0.001. This matters because critical health literacy in particular is what turns a pamphlet or a television segment into a personal decision. A woman can memorize the fact that breast screening exists, but unless she can judge that information as relevant to her own life and act on it, the knowledge stays inert. The Turkish-origin group’s advantage on precisely these higher-order dimensions may help explain other behavioral differences the study recorded.

When the researchers turned to the ASSISTS scale, which measures the factors that support women’s breast cancer prevention behaviors, the overall scores were remarkably similar across all four ethnic groups, with no statistically significant difference in the total score. Yet one subscale broke the pattern: stress management was significantly higher among women of Turkish origin than among the others, at p = 0.004. In other words, the raw motivation and general orientation toward prevention were comparable everywhere, but the specific psychological resources that sustain preventive habits were not. This is perhaps the study’s most subtle finding. It suggests that the ethnic differences in screening rates documented earlier in the paper are not simply a matter of one group caring about breast cancer and another not caring. Something else—something closer to the machinery of daily self-care—differs between the communities.

That interpretation gained strength from the regression analyses. Health literacy significantly predicted breast cancer prevention behaviors among women of Assyrian, Kurdish, and Arab origin, with standardized beta coefficients of 0.236, 0.505, and 0.384 respectively, and p values ranging from 0.021 to below 0.001. The strongest effect appeared in the Kurdish-origin group, where health literacy explained a substantial share of the variation in prevention behavior. Notably, the authors report that the total ASSISTS score itself did not differ significantly by ethnicity, which sharpens the implication: the same level of preventive orientation can translate into very different actual behaviors depending on how well a woman can access, understand, and critically use health information. Literacy, in this sense, is the bridge between intention and action—and the bridge is stronger in some communities than in others.

The authors draw a conclusion that reaches well beyond Mardin. Ethnic differences in breast cancer prevention behaviors, they argue, are related not only to the level of knowledge women possess but to how that knowledge translates into behavior. Awareness training and behavioral models, they write, should be planned and implemented with local opinion leaders and community representatives at the table, taking ethnic and cultural characteristics into account. This is a practical prescription with real logic behind it. A health message delivered in the wrong language, by an outsider, through a channel a community does not trust, will fail even if its content is scientifically impeccable. Conversely, a message carried by a trusted local figure, framed in familiar cultural terms, can move a community where generic campaigns stall. The study’s evidence that motivation is similar across groups while translation of motivation into action differs makes this community-embedded approach especially promising.

For a global audience, the study is a reminder that health inequities are rarely as simple as access to a clinic. All 403 women lived in the same city and were nominally served by the same health system, yet their screening rates, anxiety levels, and literacy profiles diverged along ethnic lines in ways that statistics could clearly detect. Breast cancer prevention, the findings imply, is not a single intervention but a chain of psychological and social steps—feeling that health matters, understanding information, judging it relevant, and converting it into a clinic visit or a monthly self-exam—and each link can be forged differently in different cultural settings. As screening programs worldwide confront persistent gaps among minority and ethnic communities, the Mardin data offer both a warning and a template: measure the differences honestly, respect the cultures involved, and build prevention from the community outward rather than from the campaign inward.

Subject of Research: Ethnic differences in health anxiety, health literacy, and breast cancer prevention behaviors among women

Article Title: Identifying factors influencing health anxiety, health literacy, and breast cancer prevention behaviors of women from different ethnic groups

Article References: Yiğitalp, G., Olğaç Ak, K., & Bayram Değer, V. (2026). Identifying factors influencing health anxiety, health literacy, and breast cancer prevention behaviors of women from different ethnic groups. BMC Psychology. https://doi.org/10.1186/s40359-026-05594-z

Image Credits: AI Generated

DOI: 10.1186/s40359-026-05594-z

Keywords: breast cancer, health literacy, health anxiety, ethnicity, cancer prevention, women's health, screening, clinical breast examination, health behavior, cultural differences, Türkiye, public health

The premise behind the scale is deceptively simple. Anxiety about a chronic, relapsing disease does not remain a purely internal experience; it leaks into behavior. Patients with pemphigus vulgaris may inspect their skin and mouths repeatedly for the first sign of a new blister, avoid foods or physical activities that they believe could trigger lesions, or withdraw from social and occupational situations out of fear that their disease will flare. These behaviors are well documented in other anxiety-related conditions, from the body checking seen in eating disorders to the safety behaviors of social phobia and the fear-avoidance beliefs that perpetuate chronic back pain. Yet, as the authors note in their comprehensive review of the literature, no disease-specific instrument existed to measure such behaviors in pemphigus, despite guidelines recommending regular mental health screening for these patients.

To build the scale, the researchers began where good instrument development always begins: with the patients themselves. Items were generated with input from people living with pemphigus vulgaris and from specialist physicians who treat the disease, ensuring that the questions reflected the real texture of daily worry rather than a generic anxiety checklist. Face and content validity were then established through participant and expert ratings of each item, a process that confirms both that the questions make sense to the people answering them and that experts agree the items actually measure the intended construct. This collaborative approach matters, because behaviors as intimate as skin inspection or dietary avoidance can easily be misunderstood or trivialized by questionnaires designed for other populations.

The psychometric evaluation drew on a sample of 160 participants with pemphigus vulgaris, who completed the SCABS along with validated measures of depression, anxiety, and fear of disease recurrence. The team then subjected the data to a battery of standard scale-development analyses, including exploratory factor analysis, interitem reliability analyses, correlations, and analysis of variance. Exploratory factor analysis is a statistical technique that examines patterns of correlation among questionnaire items to discover whether they cluster around underlying dimensions; in this case, the analysis identified three coherent subscales, which the researchers labeled Checking and Worrying, Contact Avoidance, and Ingested and Situational Avoidance.

Each of the three subscales demonstrated strong interitem reliability, meaning that the items within each cluster consistently measured the same underlying behavior. The structure itself is clinically revealing. The Checking and Worrying subscale captures the cognitive and repetitive side of health anxiety, the compulsive surveillance of one’s own body for signs of recurrence. Contact Avoidance reflects the tendency to steer clear of physical contact or situations that might traumatize the skin, while the Ingested and Situational Avoidance subscale measures avoidance of foods, drinks, and specific circumstances that patients fear could provoke new blisters. That these three dimensions emerged independently suggests that anxiety in pemphigus expresses itself through distinct behavioral channels, each of which may require a different therapeutic approach.

Crucially, the scale did more than divide neatly into subscales; it also behaved the way a valid measure should when compared with external criteria, a property psychometricians call construct validity. Subscale and total scores were associated with remission status, depression, anxiety, fear of recurrence, and occupational impairment. In other words, patients who were not in remission, who reported more depressive and anxious symptoms, who feared their disease would return, or whose ability to work was compromised tended to score higher on checking and avoidance. These convergent relationships support the idea that the SCABS is measuring a real and consequential psychological phenomenon, not an artifact of questionnaire design.

The context for this work is a growing body of evidence that the psychological burden of pemphigus vulgaris has been chronically underestimated. Studies cited by the authors report elevated rates of depression and anxiety in pemphigus patients, including in those in clinical remission, along with post-traumatic stress symptoms, reduced quality of life, and sexual and social difficulties. A 2025 survey study by the same group documented the broad psychosocial burden of autoimmune blistering diseases, and other research has linked stressful life events to disease activity. Patients whose lesions are visible may face social appearance anxiety, and even those in complete remission can carry persistent psychological morbidity. The European S2K guidelines on pemphigus management explicitly recommend regular mental health screening, yet few disease-specific tools have been available to make such screening meaningful.

Why does a measurement tool matter so much? Because behavior is where anxiety becomes disabling. A patient who spends an hour each morning examining her skin, refuses to eat anything but soft bland foods, and has stopped hugging her children is suffering in ways that a routine dermatological exam will never detect. Avoidance, as the anxiety-treatment literature has long recognized, provides short-term relief but reinforces fear over time, narrowing a patient’s life and sometimes worsening disease outcomes through stress and delayed recognition of genuine flares. Cognitive-behavioral therapy, which has strong evidence in anxiety disorders and has shown benefit in other chronic autoimmune conditions such as lupus erythematosus and multiple sclerosis, targets exactly these checking and avoidance patterns. But clinicians cannot intervene effectively on behaviors they cannot see, and the SCABS gives them a way to see them.

The authors are careful to frame this as a preliminary validation. The scale was tested in a single sample of 160 participants, recruited with assistance from the International Pemphigus and Pemphigoid Foundation, and further work will be needed to confirm its structure in independent populations, establish test-retest reliability, and determine how scores change with treatment. The study received ethics exemption from the Yale University Institutional Review Board, and the authors declared no competing interests. Data are available from the corresponding author on reasonable request, with identifying information removed. These are the standard caveats of early instrument development, and they do not diminish the significance of filling an empty niche: until now, no validated scale existed specifically for checking and avoidance in pemphigus vulgaris.

The broader lesson extends beyond a single rare disease. Pemphigus vulgaris belongs to a family of autoimmune blistering conditions whose patients, research suggests, carry a heavy and often invisible psychological load. As immunologists develop increasingly effective biologics and immunosuppressive regimens, the frontier of care is shifting from survival to quality of life, and that frontier runs directly through mental health. Instruments like the SCABS, and its companion measure for fear of disease recurrence developed by the same group, represent a quiet revolution in dermatology: the recognition that a disease of the skin is also a disease of the mind, and that measuring worry, checking, and avoidance is as much a part of good medicine as measuring antibody titers. For the hundreds of thousands of people worldwide living with pemphigus, a short questionnaire that asks about the behaviors they have been hiding may be the first step toward treatment that addresses the whole patient, blisters and all.

Subject of Research: Development and validation of a scale measuring skin checking and avoidance behaviors in pemphigus vulgaris

Article Title: Development and preliminary validation of the skin checking and avoidance behaviors scale in pemphigus vulgaris

Article References: Development and preliminary validation of the skin checking and avoidance behaviors scale in pemphigus vulgaris. (n.d.). https://doi.org/10.1007/s00403-026-04969-x

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04969-x

Keywords: pemphigus vulgaris, health anxiety, skin checking, avoidance behaviors, psychometrics, scale validation, autoimmune blistering disease, mental health screening, depression, anxiety, fear of recurrence, quality of life